See also this year's filing and all EDGAR filings for this company.
PDF Report 0001505512_2024_Regulus_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001505512, Regulus Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 28,179,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 33,000 |
| 2 | PropertyPlantAndEquipmentNet | 1,061,000 |
| 3 | remainder_Assets | 1,477,000 |
| 4 | LiabilitiesCurrent | 8,508,000 |
| 5 | LiabilitiesNoncurrent | 1,055,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 10,063,155 |
| 9 | ResearchAndDevelopmentExpense | 24,541,433 |
| 10 | remainder_Expenses | 540,267 |
| 11 | remainder_Revenues | 1,380,547 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | -5,074 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 30,750,000 |
| 1 | Liabilities | 9,563,000 |
| 2 | Expenses | 35,144,855 |
| 3 | Revenues | 1,380,547 |
| 4 | StockholdersEquity | 21,187,000 |
| 5 | NetIncome | -33,764,308 |
| 6 | ComprehensiveNetIncome | -33,766,845 |
| 7 | BaseVar | 38,421,738 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.616 |
| 9 | EconomicCapitalRatio | 1.98 |
Edgar->Model Mapping
Feature Distribution
Change over Time
